Evolutionary medicine—Apolipoprotein L1 in human health and disease

2021 ◽  
pp. 117-129
Author(s):  
Etty Kruzel-Davila ◽  
Karl Skorecki
Author(s):  
Sandra Breum Andersen ◽  
B. Jesse Shapiro ◽  
Christina Vandenbroucke-Grauls ◽  
Marjon G.J. de Vos

Bacteria and other microbes play a crucial role in human health and disease. Medicine and clinical microbiology have traditionally attempted to identify the etiological agents that causes disease, and how to eliminate them. Yet this traditional paradigm is becoming inadequate for dealing with a changing disease landscape. Major challenges to human health are noncommunicable chronic diseases, often driven by altered immunity and inflammation, and persistent communicable infections whose agents harbor antibiotic resistance. It is increasingly recognized that microbe-microbe interactions, as well as human-microbe interactions are important. Here, we review the “Evolutionary Medicine” framework to study how microbial communities influence human health. This approach aims to predict and manipulate microbial influences on human health by integrating ecology, evolutionary biology, microbiology, bioinformatics and clinical expertise. We focus on the potential promise of evolutionary medicine to address three key challenges: 1) detecting microbial transmission; 2) predicting antimicrobial resistance; 3) understanding microbe-microbe and human-microbe interactions in health and disease, in the context of the microbiome.


Author(s):  
Peter Gluckman ◽  
Felicia Low

Evolutionary medicine, sometimes referred to as Darwinian medicine, is an emerging academic field that employs evolutionary principles to aid in the understanding of human health and disease at the levels of both the individual and the population. While its main value lies in giving an ultimate (evolutionary) perspective to patterns of health and disease, there are areas of clinical medicine and public health where it has direct application. Whereas the bulk of clinical medicine is focused on issues of proximate causation and, in particular, pathophysiological mechanisms and their treatment, evolutionary perspectives focus on understanding how and why traits evolved and how they confer greater or lesser disease risk. Evolutionary perspectives also give weight to ecological dimensions, particularly the positioning of individuals within their social and environmental context, and also their relationship to other organisms, including gut microbiota, parasites, and infectious agents. A core principle of evolutionary medicine is that selection has operated to optimize reproductive fitness, and that this is not the same as selection for health or longevity. Indeed, selection pressures wane with age, and humans have had increasing median lifespans in recent centuries, leading to greater incidence of diseases that occur in the post-reproductive period. Another distinctive feature is an appreciation of the role of cultural evolution and technology in changing the environments within which humans now live—changes that can exaggerate the mismatch between evolved biology and the environment, with health consequences. Selection can occur not only at the level of the whole organism but also at the level of a cellular clone, and evolutionary concepts have become important in understanding the progression of cancer. More controversially, evolutionary concepts are contributing to understanding the origin of human behavior at both an individual and a group level, and also to understanding some psychiatric symptomatology. Evolutionary history also contributes to disease risk through anatomical and biochemical vestiges such as the appendix or the lack of the gene to synthesize ascorbic acid (and prevent scurvy); through genetic mechanisms such as founder effects and balancing selection; and through the evolution of defense mechanisms that may operate excessively (e.g., autoimmune disorders), which can explain much common symptomatology (e.g., fever). Being well versed in evolutionary concepts enables medical students and clinicians to integrate factual knowledge of cellular biology, physiology, and anatomy into a meaningful framework, thus promoting a better understanding of human health and disease. This sentiment is being embraced by a growing number of medical schools worldwide as evidenced by the inclusion of evolutionary medicine into the core curricula.


Author(s):  
Sandra Breum Andersen ◽  
B. Jesse Shapiro ◽  
Christina Vandenbroucke-Grauls ◽  
Marjon G.J. de Vos

Bacteria and other microbes play a crucial role in human health and disease. Medicine and clinical microbiology have traditionally attempted to identify the etiological agents that causes disease, and how to eliminate them. Yet this traditional paradigm is becoming inadequate for dealing with a changing disease landscape. Major challenges to human health are noncommunicable chronic diseases, often driven by altered immunity and inflammation, and persistent communicable infections whose agents harbor antibiotic resistance. It is increasingly recognized that microbe-microbe interactions, as well as human-microbe interactions are important. Here, we review the “Evolutionary Medicine” framework to study how microbial communities influence human health. This approach aims to predict and manipulate microbial influences on human health by integrating ecology, evolutionary biology, microbiology, bioinformatics and clinical expertise. We focus on the potential promise of evolutionary medicine to address three key challenges: 1) detecting microbial transmission; 2) predicting antimicrobial resistance; 3) understanding microbe-microbe and human-microbe interactions in health and disease, in the context of the microbiome.


2018 ◽  
Author(s):  
Sandra Breum Andersen ◽  
B. Jesse Shapiro ◽  
Christina Vandenbroucke-Grauls ◽  
Marjon G.J. de Vos

Bacteria and other microbes play a crucial role in human health and disease. Medicine and clinical microbiology have traditionally attempted to identify the etiological agents that causes disease, and how to eliminate them. Yet this traditional paradigm is becoming inadequate for dealing with a changing disease landscape. Major challenges to human health are noncommunicable chronic diseases, often driven by altered immunity and inflammation, and persistent communicable infections whose agents harbor antibiotic resistance. It is increasingly recognized that microbe-microbe interactions, as well as human-microbe interactions are important. Here, we review the “Evolutionary Medicine” framework to study how microbial communities influence human health. This approach aims to predict and manipulate microbial influences on human health by integrating ecology, evolutionary biology, microbiology, bioinformatics and clinical expertise. We focus on the potential promise of evolutionary medicine to address three key challenges: 1) detecting microbial transmission; 2) predicting antimicrobial resistance; 3) understanding microbe-microbe and human-microbe interactions in health and disease, in the context of the microbiome.


Membranes ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 411
Author(s):  
Nader Kameli ◽  
Anya Dragojlovic-Kerkache ◽  
Paul Savelkoul ◽  
Frank R. Stassen

In recent years, plant-derived extracellular vesicles (PDEVs) have gained the interest of many experts in fields such as microbiology and immunology, and research in this field has exponentially increased. These nano-sized particles have provided researchers with a number of interesting findings, making their application in human health and disease very promising. Both in vitro and in vivo experiments have shown that PDEVs can exhibit a multitude of effects, suggesting that these vesicles may have many potential future applications, including therapeutics and nano-delivery of compounds. While the preliminary results are promising, there are still some challenges to face, such as a lack of protocol standardization, as well as knowledge gaps that need to be filled. This review aims to discuss various aspects of PDEV knowledge, including their preliminary findings, challenges, and future uses, giving insight into the complexity of conducting research in this field.


2021 ◽  
pp. 002203452110018
Author(s):  
J.T. Wright ◽  
M.C. Herzberg

Our ability to unravel the mysteries of human health and disease have changed dramatically over the past 2 decades. Decoding health and disease has been facilitated by the recent availability of high-throughput genomics and multi-omics analyses and the companion tools of advanced informatics and computational science. Understanding of the human genome and its influence on phenotype continues to advance through genotyping large populations and using “light phenotyping” approaches in combination with smaller subsets of the population being evaluated using “deep phenotyping” approaches. Using our capability to integrate and jointly analyze genomic data with other multi-omic data, the knowledge of genotype-phenotype relationships and associated genetic pathways and functions is being advanced. Understanding genotype-phenotype relationships that discriminate human health from disease is speculated to facilitate predictive, precision health care and change modes of health care delivery. The American Association for Dental Research Fall Focused Symposium assembled experts to discuss how studies of genotype-phenotype relationships are illuminating the pathophysiology of craniofacial diseases and developmental biology. Although the breadth of the topic did not allow all areas of dental, oral, and craniofacial research to be addressed (e.g., cancer), the importance and power of integrating genomic, phenomic, and other -omic data are illustrated using a variety of examples. The 8 Fall Focused talks presented different methodological approaches for ascertaining study populations and evaluating population variance and phenotyping approaches. These advances are reviewed in this summary.


Sign in / Sign up

Export Citation Format

Share Document